Article
Molecular avenues in targeted doxorubicin cancer therapy
1 Apr 2020
Abstract excerpt
In recent, intra- and inter-tumor heterogeneity is seen as one of key factors behind success and failure of chemotherapy. Incessant use of doxorubicin (DOX) drug is associated with numerous post-treatment debacles including cardiomyopathy, health disorders, reversal of tumor and formation of secondary tumors. The module of cancer treatment has undergone evolutionary changes by achieving crucial understanding on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
